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Abstract
Background: The low copy repeats (LCRs) in chromosome 15q11-q13 have been recognized as breakpoints (BP)
for not only intrachromosomal deletions and duplications but also small supernumerary marker chromosomes 15,
sSMC(15)s, in the forms of isodicentric chromosome or small ring chromosome. Further characterization of copy
number changes and methylation patterns in these sSMC(15)s could lead to better understanding of their
phenotypic consequences.
Methods: Routine G-band karyotyping, fluorescence in situ hybridization (FISH), array comparative genomic
hybridization (aCGH) analysis and methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)
assay were performed on two Chinese patients with a sSMC(15).
Results: Patient 1 showed an isodicentric 15, idic(15)(q13), containing symmetrically two copies of a 7.7 Mb
segment of the 15q11-q13 region by a BP3::BP3 fusion. Patient 2 showed a ring chromosome 15, r(15)(q13), with
alternative one-copy and two-copy segments spanning a 12.3 Mb region. The defined methylation pattern
indicated that the idic(15)(q13) and the r(15)(q13) were maternally derived.
Conclusions: Results from these two cases and other reported cases from literature indicated that combined
karyotyping, aCGH and MS-MLPA analyses are effective to define the copy number changes and methylation
patterns for sSMC(15)s in a clinical setting. The characterized genomic structure and epigenetic pattern of
sSMC(15)s could lead to further gene expression profiling for better phenotype correlation.
Keywords: Isodicentric chromosome, Ring chromosome, 15q11-q13, Array comparative genomic hybridization
(aCGH), Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)
Background
The low copy repeats (LCRs) clustered in the chromo-
some 15q11-q13 region are known breakpoints 1 to 5
(BP1-5) for meiotic non-allelic homologous recom-
bination which results in interstitial deletions and
duplications [1]. Deletions of this region account for
approximately 70 % of patients with Prader-Willi
syndrome (PWS, OMIM#176270) and Angelman syn-
drome (AS, OMIM#105830). Reciprocal duplications
of 15q11-q13 can cause autism, developmental de-
lays, intellectual disability, ataxia, seizures, and be-
havioral problems (OMIM#608636). The PWS/AS critical
region (PWACR) of 15q11-q13 contains many imprinting
genes and shows the parental-origin effects [2]. In addition
to intrachromosomal rearrangements, small supernumer-
ary marker chromosomes 15, sSMC(15)s, in the forms of
an inverted duplication (inv dup) or an isodicentric
chromosome (idic) and a small ring chromosome, were
also derived from rearrangements of the LCRs of 15q11-
q13 [3]. The phenotypic consequences of these sSMC(15)
are associated with their genomic structure, parental-origin
imprinting effects and level of mosaicism [4].
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Most sSMC(15)s take the form of a dicentric inv dup
and can be classified into two groups: small sSMC(15)s
and large sSMC(15)s. The small sSMC(15)s have
breakpoints at the BP1 or BP2 proximal to the critical
region and usually clinically irrelevant, while the large
sSMC(15)s frequently extend beyond the BP3 to in-
clude the critical region and are frequently associated
with abnormal phenotypes [5–17]. However, unex-
pected level of structural complexity including asym-
metrical breakpoints, unequal size of inverted arms,
and multiple types of atypical rearrangements among
sSMC(15)s were noted [9, 12, 14, 15]. Previous studies
showed that de novo sSMC(15)s characterized molecu-
larly were of maternal origin [5, 7, 9, 10, 17]. It has
been recognized that maternal duplication of this re-
gion will produce abnormal phenotype but paternal
duplication carriers are commonly unaffected. How-
ever, recent studies showed that patients with paternal
duplication of 15q11-q13 may also have mild abnormal
phenotype [8, 17]. In addition to the genomic structure
and parental origin, the level of mosaicism might also
alter the risk associated with an abnormal phenotype.
A mitigate effect correlating the mild phenotype of
motor and speech development delay with the percent-
age and the type of cell lineages containing the sSMC(15)
was suggested [10, 13, 15]. However, results from a large
case series showed that about 60 % percent mosaic sSMC
cases with clinical abnormalities had no direct correlation
to the level of mosaicism in the peripheral blood and there
is no simple relationship between clinical abnormalities
and sSMC mosaicism [4].
The application of array comparative genomic
hybridization (aCGH) analysis has proven very effective
in defining the breakpoints, copy number changes, and
gene content for sSMC(15)s [11, 12, 14–17]. Recently,
methylation-specific multiplex ligation-dependent probe
amplification (MS-MLPA), a rapid and cost-effective
technique with high specificity and sensitivity, has been
introduced for genetic analysis of copy number changes
and methylation patterns [18–21]. In this study, we
present copy number changes and methylation pattern
from an isodicentric chromosome 15 and a small ring
chromosome 15. Review of literature found five reports
with combined copy number and methylation analyses
on 34 cases of sSMC(15)s and two cases of small ring
chromosome 15 [17, 22–25]. These results demonstrate
that combined karyotype, FISH, aCGH and MS-MPLA
analyses could be used in a clinical setting effectively to
define genomic structure, parental origin and level of
mosaicism for sSMC(15)s.
Results
Patient 1 is a 3-year-old girl. She was born at 41 weeks
of gestation from an uneventful pregnancy and delivered
by Caesarean section. Her birth weight was 3,550 g
(75th percentile) and birth length was 51 cm (85th per-
centile). She showed head control at 6 months, standing
with aid at 18 months, and walking not steadily at
26 months. Her verbal language was nearly absent and
no visual contact. The daily life was completely taken
care by the family. She showed no dysmorphic features
and no record of seizures but was hypotonia and impul-
sive. She failed to follow instructions and lacked response
to commands. Electroencephalography (EEG) study and
nuclear magnetic resonance imaging (MRI) were normal.
The parents were healthy and non-consanguineous.
The father was 40-year-old and the mother was 42-
year-old at the time of her birth. Parental chromosome
studies were normal.
For patient 1, karyotyping analysis showed a super-
numerary isodicentric chromosome 15, 47,XX,+i-
dic(15)(pter→ q13.1::q13.1→ pter), in all cells examined
(Fig. 1a). FISH test was performed using dual color probes
for the SNRPN gene at 15q11.2 and a control locus at
15qter. Of the 20 metaphase cells analyzed, the normal
chromosomes 15 showed positive hybridization signals on
the targeted loci from both probes and the idic(15) had
two strong signals from the SNRPN probe but no signal
from the control probe. Of the 50 interphases examined,
four signals for the SNRPN probe and two signals for the
control probe were noted (Fig. 1b). The result confirmed
that the idic(15) contained two copies of the SNRPN gene
region. The aCGH result indicated a 7.7 Mb duplication
of chromosome 15q11-q13 (chr15:18,362,355-26,110,139)
including genes from A26B1 to HERC2. The log2 ratio
(L2R) was 0.885, indicating that the idic(15)(q13.1) was
composed of two copies of the 15q11-q13 region with a
breakage-fusion event occurred at BP3 (Fig. 1c). The
MLPA result showed four copies for this chromosomal
fragment by an increased mean peak height ratio of 2.0
(Fig. 1d). For the MS-MLPA in a normal control, the four
probes for the SNRPN gene (a maternally methylated se-
quence containing a HhaI restriction site) decreased half
of the peak height ratio, indicating the presence of one
Hha I digested paternal unmethylated copy and another
Hha I undigested maternal methylated copy. In patient 1,
the MS-MLPA result showed a one-fourth decrease of the
peak height ratio after Hha I digestion, indicating the
presence of one copy unmethylated paternal SNRPN and
three copies of methylated maternal SNRPN (Fig. 1e).
These results indicated that the idic(15) was symmetric
and of maternal origin.
Patient 2 was a six-year-old girl. She was born at
39 weeks of gestation from an uneventful pregnancy and
delivered by Caesarean section. She could sit without aid
at age one year but walk clumsy and stumbled at
25 months. Her language ability was limited. She
attended special educational training but made no much
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progress. She had intellectual disability, autistic like be-
haviors, hyperphagia and hyperactivity but no dysmorphic
features. Sleep problem and epileptic seizure were not
known in patient history. According to her parents, the
girl could follow simple instructions and fetch small
things. She could eat almost by herself but never achieved
sphincter control. Her parents were healthy and they were
23-year-old at the time of her birth.
For patient 2, chromosome analysis performed on
100 metaphase cells from cultured peripheral blood
lymphocytes showed a mosaic pattern for a supernumer-
ary small ring chromosome 15, 47,XX,+r(15)(q13)[32]/
46,XX[68] (Fig. 2a). The aCGH analysis revealed unique
copy number changes in the 12.3 Mb region of 15q11-q13
(chr15:18,362,355-30,701,573) encompassing genes from
A26B1 to CHRNA7. Starting from the proximal to the dis-
tal end at BP5, a 1.571 Mb tetrasomic segment of 15q11.1-
q11.2 (chr15:18,362,355-19,934,192, L2R:1.000, proximal
to BP1 with polymorphic copy number variants), a
2.404 Mb trisomic segment at 15q11.2 (chr15:20,418,129-
22,821,963, L2R:0.360, from BP1 to between BP2/BP3),
a 4.974 Mb tetrasomic segment of 15q11.2-q13.1
(chr15:23,020,445-27,994,906, L2R:0.727, from BP2/
BP3 to BP3/BP4), followed by a 1.791 Mb trisomic seg-
ment (chr15: 28,910,278-30,701,573, L2R:0.350, from
BP4 to BP5) were delineated (Fig. 2b). The MLPA re-
sult revealed an increased mean peak height ratio of
1.5 in segment from gene TUBGCP5 to SNRPN and a
ratio of 2.0 in segment from UBE3A to APBA2. The
results indicated that the r(15) had alternative two-
copy and one-copy segments (Fig. 2c). The MS-MLPA
result showed a one-fourth decrease of the peak height
ratio after digestion, indicating that the duplication
segment within the r(15) was methylated and of mater-
nal origin (Fig. 2d).
Discussion and conclusion
Currently, more than 1300 similar sSMC(15) cases (pub-
lished or not) are collected in the online sSMC database
(http://ssmc-tl.com/sSMC.html). Carefully checking the
website and review of literatures found five reports with
combined karyotype, aCGH/SNP and methylation ana-
lyses on 34 cases of idic(15) and two cases of small r(15)
[17, 22–25]. The genomic structures and methylation
patterns from these cases and our two cases are summa-
rized in Table 1. For the formation of de novo idic(15),
different types of breakage-fusion events including sym-
metrical BP3::BP3 and BP4::BP4 and asymmetric
BP3::BP4, BP3::BP5 and BP4::BP5 were noted (Table 1).
These observations indicated that the de novo idic(15)s
Fig. 1 Karyotyping, FISH, aCGH and MS-MLPA results in patient 1. a. The chromosome image shows a normal pair of chromosome 15 and the
extra idic(15). b. Metaphase and interphase FISH results show two copies of the SNRPN gene in the idic(15) (SNRPN red, 15qter green). c. The
aCGH chromosome view (up) and gene view (bottom) reveal the breakpoint location and a 7.7 Mb duplication. d. The MS–MLPA pattern shows a
peak height ratio value of 2 (four copies) in chromosome 15 (bottom) in comparison with a ratio value of 1 (two copies) from a normal control
(upper). e. The MS-MLPA pattern indicates a methylation percentage of 0.75 in four SNRPN recognition sites in patient 1 (bottom) in comparison
of 0.5 from a normal control (upper)
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Table 1 A summary of sSMC(15) defined by karyotype, aCGH or SNP, and methylation analyses
SMC15 Test Methods Patient
Number




trc(15), idic(15) + Nimblegen + MS-SB 2 11y,
26y














de novo BP3::BP3,BP2-BP3:: Maternal [17] Ageeli EA,
et al. 2014





+ Agilent + MS-PCR 1 2y F de novo BP3::BP3 Maternal [24] Tan E-S, et
al. 2014








Maternal [25] Aypar U,
et al. 2014
idic(15) + Agilent + MS-MLPA 1 3y F de novo BP3::BP3 Maternal This report
r(15) + Agilent + MS-MLPA 2 1d,
7y
M, M unk BP2/BP3::,BP3::BP3 Maternal [25] Aypar U,
et al. 2014
r(15) + Agilent - MS-MLPA 1 6y F de novo BP5::BP5> > BP2/
BP3::BP3/BP4
Maternal This report
Abbreviations: MS methylation sensitive, SB Southern blot; + = yes; − = not; m =month; y = year; unk, unknown
Fig. 2 Karyotyping, aCGH and MS-MLPA results in patient 2. a. The chromosome image shows a normal pair of chromosome 15 and the extra
r(15). b. The aCGH chromosome view (up) and gene view (bottom) reveal the breakpoint location and a 12.3 Mb. c. The MS-MLPA pattern shows
peak height ratio value of 1.5 to 2.0 (three or four copies) in chromosome 15 (bottom) in comparison with a ratio value of 1 (two copies) from a
normal control (upper). d. The MS-MLPA pattern indicates methylation aberration of 0.75 in four SNRPN recognition sites in patient 2 (bottom) in
comparison with 0.5 from a normal control (upper)
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originated from maternal meiotic crossing-over event
between paired or mis-paired LCRS of homologous
chromosomes in pachytene and followed by non-
disjunction in the subsequent divisions [3]. Several
modes of formation for inv dup or idic chromosome
have been proposed. The most plausible mode of forma-
tion is the U-type exchange resulting from crossover
mistakes of chromatids of two homologous chromo-
somes during meiosis [3] (Fig. 3a). Supernumerary small
ring chromosome for the 15q11-q13 is an uncommon
chromosomal abnormality and also likely derived from
breakage and fusion event at the LCRs of 15q11-q13.
However, the small r(15) from the two cases in the lit-
erature and our patient 2 showed break-fusions occurred
between BPs (BP2/BP3 or BP3/BP4). The complex copy
number changes and the variable breakage-fusion points
within the r(15) may be explained by a two-step process
including initial ring formation by a break-fusion event
at the LCRs, an intermediate double ring from ring
DNA replication, and a secondary asymmetric break-
fusion event to introduce segmental duplications and
deletions between BPs (Fig. 3b) [26, 27]. Therefore, for
small supernumerary r(15), ring structure instability and
secondary rearrangements should be considered.
Our two cases and almost all reported de novo cases
of idic(15)s showed a genomic structure including
PWACR and a methylation pattern of maternal origin
[5–17, 22–25]. As reported from previous analyses,
clinical phenotypes for sSMC(15)s are related with the
duplication region containing the PWACR and the mater-
nally derived homologue of chromosome 15q [13, 17]. A
comparison of clinical features between our patients and
among those previously reported cases with similar size of
duplication noted that patient 2 showed a relatively mild
phenotype despite a larger size containing genes from BP1
to BP5. The presence of normal cells from the mosaic
ring sSMC(15) might alleviate the severity of the clin-
ical manifestation. Since routine karyotyping analysis
was only done for cells from peripheral blood culture,
the percentage of the mosaic r(15) in other tissues was
not known. Micro-invasive methods to access other
types of tissues, especially muscular and neurologic
Fig. 3 Mechanisms for the idic(15) and ring 15. a. A schematic drawing shows the U-type exchange during meiosis for the formation of the
idic(15) with a BP3::BP3 fusion. b. A schematic drawing shows the two-step process for the formation of r(15) from the initial ring formation with
break-fusion at BP5, the formation of double ring through replication, and subsequent asymmetric breakage-fusion for segmental duplication and
deletion (thin line for breakpoint, dash line for joining point)
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tissues, are needed to evaluate the mosaic pattern for
sSMC(15)s. The gene content within sSMC(15)s and
the parental-origin imprinting effects could be the de-
termine factors affecting the phenotype [22, 28]. Patient
1 had a 7.7 Mb BP1-BP3 duplication which contains
genes involving in developmental or neurological dis-
eases. The BP1-BP2 region contains NIPA1, NIPA2 and
CYFIP1 genes which are associated with the central
nervous system development or function [29–31]. The
BP2-BP3 region contains paternally expressed genes
MKRN3, MAGEL2, NDN and SNRPN; these four genes
are implicated in the autism disorder [17, 32]. The ma-
ternally expressed UBE3A gene is exclusively-expressed
in brain tissue and the neurodevelopmental complex-
ities are associated with increased UBE3A in dup15q
syndrome [33, 34]. The NDN gene is an imprinted gene
expressed exclusively from the paternal allele, which is
associated with neurological and muscular disorder and
implicated as a negative growth regulator in human
cancer [35, 36]. Patient 2 had a 12.3 Mb duplication
involving BP1-BP5 region that extending to gene
CHRNA7. The clinical phenotype like speech delay, hy-
perphagia, hyperactivity, mental retardation, no facial
dysmorphism and no epilepsy may be influenced by
gain of dosage of CHRNA7 [17, 37, 38]. In addition to
the gene dosage effect, the gene expression may also
contribute to the variability of the phenotypes which
were influenced in unexpected ways through epigenetic
changes [22]. Further elucidation of cellular functions
and molecular pathways of the genes within the BP1-
BP5 duplication region will facilitate better phenotype
prediction and therapeutic intervention.
Several molecular methods including Southern blot
analysis on methylation sensitive restriction sites, MS-
PCR, sequencing of bisulfate-treated DNA, MS-PCR
and MS-MLPA, have been introduced to define methyla-
tion pattern for sSMC(15)s [21, 22, 39]. Southern blot
and sequencing methods are more time consuming and
expensive. MS-PCR may show more variation in copy
number quantitation. The present study and several re-
ports have demonstrated that MS-MLPA is a robust,
high-throughput, rapid and inexpensive approach with
high specificity and sensitivity [22–25]. It provides
an efficient way to simultaneously detect copy num-
ber changes and DNA methylation within 15q11-q13
in a semi-quantitative manner [39]. Taken together,
combined cell-based karyotyping and FISH to detect
the chromosome structure and mosaic pattern with
DNA-based aCGH and MS-MLPA for copy number
changes and methylation patterns should be recom-
mended for clinical analysis of sSMC(15). Practice
guidelines for PWS/AS and analytic algorithms for
sSMC(15)s using this combined methods have been
proposed [25, 39].
In conclusion, we have defined the copy number
changes and methylation pattern in an idic(15) and a
r(15) from two Chinese patients by karyotyping, aCGH,
and MS-MLPA analysis. The results revealed that the
idic(15) with a BP3::BP3 fusion and a r(15) likely result-
ing from secondary breakage-fusion between BP2/BP3
and BP3/BP4 were maternally derived. Variable spectrum
of neurodevelopmental phenotype might be explained by




Two patients were referred for genetic evaluation of de-
velopmental delay, speech retardation and intellectual
disabilities at the genetic counseling clinic in Shenzhen
Maternal and Child Healthcare Hospital. This study was
approved by the hospital’s Institutional Review Board
and written informed consents were obtained from their
parents.
Karyotype analysis
Chromosome analysis was performed on G-banded
metaphases from cultured peripheral blood lympho-
cytes according to the laboratory’s standard protocols.
An extended analysis of 100 G-banded metaphase cells
was performed to allow the detection of equal or
greater than 3 % of mosaicism with 95 % confidence
interval [40].
FISH analysis
Fluorescence in situ hybridization (FISH) analysis was
performed on metaphase chromosomes and interphase
nuclei using dual color probes for the SNRPN gene at
15q11.2 and a control locus at 15qter (Cytocell Inc.) fol-
lowing the manufacturer’s instruction. Hybridization sig-
nal patterns were analyzed on twenty metaphase cells
and 50 interphase cells. FISH probe preparation, in situ
hybridization, signal scoring, and image capture were
performed as previously described [41].
Array comparative genomic hybridization (aCGH)
Genomic DNA was extracted from the peripheral blood
using the Gentra Puregene Blood kit (Qiangen, Valencia,
CA, USA). DNA concentration was measured using a
NanoDrop spectrophotometer (ND-1000, Thermo Fisher
Scientific Inc., Waltham, Mass., USA), and DNA quality
was verified by agarose gel electrophoresis. For each
case, 2 ug of patient genomic DNA was used following
the protocol from the SurePrint G3 Human CGH
8x60K Microarray Kit (Agilent Technologies, Santa
Clara, CA, USA). DNA labeling, sex-matched test/con-
trol hybridization, post hybridization washes, image scan-
ning, and data analysis were processed as previously
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described [39]. The base pair positions for detected
genomic imbalances were designated according to the
March 2006 Assembly (NCBI36/hg18) in the UCSC
Human Genome browser (http://genome.ucsc.edu/).
MS-MLPA
MLPA reagents were obtained from MRC-Holland
(Amsterdam, The Netherlands; SALSA MLPA kit ME028).
The ME028 Kit can be used to detect copy number
changes and to analyze the CpG island methylation of the
15q11 region in a semi-quantitative manner. The Kit con-
tains 32 probes specific for sequences in the PWACR and
14 reference probes outside the region. Four of the
PWACR specific probes in the SNRPN gene contain a rec-
ognition site for the methylation sensitive HhaI enzyme
and can be used for the presence of aberrant methylation
patterns in the 15q11 locus. The NDN gene also contains
methylation probes while it has a known tendency to over-
digest resulted in variable results. The experiment proce-
dures were performed following the manufacturer’s proto-
col [18, 42]. The MS-MLPA data was imported into the
software Coffalyser.Net (designed by MRC-Holland) to
analyze both the copy number variation and the methyla-
tion profile.
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